China Announces M&A Guidelines For Nine Industries, Including Pharma
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities issued guidelines for M&As in nine industries, including pharma to help overcome fragmented development, low professionalism, inadequate healthy development direction, and excess capacity.